FDA ta ba da izinin COVID-19 Booster Shot ga mutanen da ba su da ƙarfi

Wadatacce

• Bita don

Tare da sabon bayani game da COVID-19 da ke fitowa kowace rana-tare da tashin hankali a lokuta a cikin ƙasa baki ɗaya-yana da ma'ana idan kuna da tambayoyi game da yadda za ku fi samun kariya, koda kuwa an yi muku cikakken allurar rigakafi. Kuma yayin da ake magana game da yuwuwar harba COVID-19 mai ƙarfi a cikin 'yan gajeren makonni da suka gabata, karɓar ƙarin allura zai zama gaskiya ga wasu nan ba da jimawa ba.

Hukumar Abinci da Magunguna ta ba da izinin allurai na uku na Moderna da Pfizer-BioNTech COVID-19 na alluran rigakafi ga mutanen da ba su da rigakafi, in ji kungiyar a ranar Alhamis. Matakin na zuwa ne yayin da bambance-bambancen yankin na Delta ke ci gaba da yaduwa a duk faɗin ƙasar, yana ƙidaya kashi 80 na COVID-19 a cikin Amurka, bisa ga bayanan kwanan nan daga Cibiyoyin Kula da Cututtuka da Cututtuka. (Mai alaƙa: Yaya Tallafin COVID-19 yake da inganci?)

Kodayake coronavirus yana yin barazana a bayyane ga kowa, da samun raunin tsarin garkuwar jiki-wanda shine lamarin kusan kashi uku na yawan jama'ar Amurka-"na iya sa ku iya kamuwa da rashin lafiya daga COVID-19," a cewar CDC. Kungiyar ta amince da masu garkuwar jiki a matsayin wadanda ake yi wa dashen gabobin jikinsu, wadanda ake yi musu maganin cutar daji, masu dauke da cutar kanjamau, da wadanda ke da cututtukan gada da ke shafar garkuwar jiki da dai sauransu. FDA ta fada a cikin sanarwar manema labarai ranar alhamis cewa mutanen da za su cancanci yin harbi na uku sun hada da ingantattun masu canza sassan jiki (kamar kodan, hanta, da zukata), ko kuma wadanda ke da makamancin haka.

Janet Woodcock, MD, Mukaddashin Kwamishinan FDA, a cikin wata sanarwa Alhamis, ta ce "Ayyukan na yau yana ba likitoci damar haɓaka rigakafi a cikin wasu mutanen da ke fama da rigakafi waɗanda ke buƙatar ƙarin kariya daga COVID-19."

Bincike kan kashi na uku na allurar COVID-19 don rigakafin rigakafi yana ci gaba na ɗan lokaci. Kwanan nan, masu bincike a John Hopkins Medine sun ba da shawarar cewa akwai shaidar da za ta nuna yadda allurai uku na allurar rigakafin za su iya haɓaka matakan rigakafi kan SARS-SoV-2 (aka, kwayar cutar da ke haifar da kamuwa da cuta) a cikin tsayayyun masu karɓan jujjuyawar sassan jiki, a kan kashi biyu. allurar rigakafi. Saboda galibi ana buƙatar mutanen da ke jujjuya sassan jikin mutum su cinye magunguna "don murƙushe garkuwar jikinsu da hana ƙi" dasawa, a cewar binciken, akwai damuwa kan ikon mutum na ƙirƙirar ƙwayoyin rigakafi akan kayan waje. A takaice, 24 daga cikin mahalarta 30 na binciken sun ba da rahoton sifili da za a iya gano ƙwayoyin rigakafin cutar ta COVID-19 duk da cewa an yi musu cikakkiyar allurar rigakafi. Kodayake, bayan karɓar kashi na uku, kashi ɗaya bisa uku na marasa lafiya sun ga ƙaruwa a matakan antibody. (Kara karantawa: Ga Duk abin da kuke Bukatar Ku sani Game da Cutar Coronavirus da Rigakafin rigakafi)

Kwamitin Ba da Shawarwari na Cibiyoyin Kula da Cututtuka da Rigakafi akan Ayyukan rigakafi an saita shi don ganawa ranar Juma'a don tattauna ƙarin shawarwarin asibiti game da mutanen da ba su da rigakafi. Ya zuwa yanzu, wasu ƙasashe sun riga sun ba da izinin allurar rigakafi don mutanen da ba su da rigakafi, ciki har da Faransa, Jamus, da Hungary, a cewar Jaridar New York Times.

A yanzu, har yanzu ba a amince da masu haɓakawa ba ga waɗanda ke da tsarin rigakafi na lafiya, don haka yana da mahimmanci cewa duk mutanen da suka cancanci allurar COVID-19 su karɓa. Tare da sanya abin rufe fuska, shine mafi kyawun fa'ida don kare waɗanda ke da raunin tsarin garkuwar jiki ko duk wanda bai sami harbinsu ba tukuna.

Bayanai a cikin wannan labarin daidai ne har zuwa lokacin da ake bugawa. Yayin da sabuntawa game da coronavirus COVID-19 ke ci gaba da haɓaka, yana yiwuwa wasu bayanai da shawarwari a cikin wannan labarin sun canza tun farkon bugawa. Muna ƙarfafa ku da ku bincika akai-akai tare da albarkatu kamar CDC, WHO, da sashin kula da lafiyar jama'a na gida don ƙarin sabbin bayanai da shawarwari.

Bita don